Psycheceutical Bioscience (BWVI) Stock Price
Psycheceutical Bioscience Price
Revenue has compounded at 8.8% per year over the past 17 years to 83,779.00 USD. Psycheceutical Bioscience's net margin stands at -135.6%, up from -705.1% several years earlier. The stock trades about 11,100% above its 52-week low.
Psycheceutical Bioscience stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Psycheceutical Bioscience over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Psycheceutical Bioscience stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Psycheceutical Bioscience's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Psycheceutical Bioscience Price |
|---|---|
| 7/23/2026 | 0.00 USD |
| 7/22/2026 | 0.00 USD |
| 7/21/2026 | 0.00 USD |
| 7/20/2026 | 0.00 USD |
| 7/17/2026 | 0.00 USD |
| 7/16/2026 | 0.00 USD |
| 7/15/2026 | 0.00 USD |
| 7/14/2026 | 0.00 USD |
| 7/13/2026 | 0.00 USD |
| 7/10/2026 | 0.00 USD |
| 7/9/2026 | 0.00 USD |
| 7/8/2026 | 0.00 USD |
| 7/7/2026 | 0.00 USD |
| 7/6/2026 | 0.00 USD |
| 7/2/2026 | 0.00 USD |
| 7/1/2026 | 0.00 USD |
| 6/30/2026 | 0.00 USD |
| 6/29/2026 | 0.00 USD |
| 6/26/2026 | 0.00 USD |
| 6/25/2026 | 0.00 USD |
| 6/24/2026 | 0.00 USD |
| 6/23/2026 | 0.00 USD |
| 6/22/2026 | 0.00 USD |
| 6/19/2026 | 0.00 USD |
| 6/18/2026 | 0.00 USD |
| 6/17/2026 | 0.00 USD |
| 6/16/2026 | 0.00 USD |
| 6/15/2026 | 0.00 USD |
| 6/12/2026 | 0.00 USD |
| 6/11/2026 | 0.00 USD |
| 6/10/2026 | 0.00 USD |
| 6/9/2026 | 0.00 USD |
| 6/8/2026 | 0.00 USD |
| 6/5/2026 | 0.00 USD |
| 6/4/2026 | 0.00 USD |
| 5/29/2026 | 0.00 USD |
| 5/28/2026 | 0.00 USD |
| 5/27/2026 | 0.00 USD |
| 5/26/2026 | 0.00 USD |
| 5/22/2026 | 0.00 USD |
| 5/21/2026 | 0.00 USD |
| 5/20/2026 | 0.00 USD |
| 5/19/2026 | 0.00 USD |
| 5/18/2026 | 0.00 USD |
| 5/15/2026 | 0.00 USD |
| 5/14/2026 | 0.00 USD |
| 5/13/2026 | 0.00 USD |
| 5/12/2026 | 0.00 USD |
| 5/11/2026 | 0.00 USD |
| 5/8/2026 | 0.00 USD |
| 5/7/2026 | 0.00 USD |
| 5/6/2026 | 0.00 USD |
| 5/5/2026 | 0.00 USD |
| 5/4/2026 | 0.00 USD |
| 5/1/2026 | 0.00 USD |
| 4/30/2026 | 0.00 USD |
| 4/29/2026 | 0.00 USD |
| 4/28/2026 | 0.00 USD |
| 4/27/2026 | 0.00 USD |
| 4/24/2026 | 0.00 USD |
| 4/23/2026 | 0.00 USD |
| 4/22/2026 | 0.00 USD |
| 4/21/2026 | 0.00 USD |
| 4/20/2026 | 0.00 USD |
| 4/17/2026 | 0.00 USD |
| 4/16/2026 | 0.00 USD |
| 4/15/2026 | 0.00 USD |
| 4/14/2026 | 0.00 USD |
| 4/13/2026 | 0.00 USD |
| 4/10/2026 | 0.00 USD |
| 4/9/2026 | 0.00 USD |
| 4/8/2026 | 0.00 USD |
| 4/7/2026 | 0.00 USD |
| 4/6/2026 | 0.00 USD |
| 4/2/2026 | 0.00 USD |
| 4/1/2026 | 0.00 USD |
| 3/31/2026 | 0.00 USD |
| 3/30/2026 | 0.00 USD |
| 3/27/2026 | 0.00 USD |
| 3/26/2026 | 0.00 USD |
| 3/25/2026 | 0.00 USD |
| 3/24/2026 | 0.00 USD |
| 3/23/2026 | 0.00 USD |
| 3/20/2026 | 0.00 USD |
| 3/19/2026 | 0.00 USD |
| 3/18/2026 | 0.00 USD |
| 3/17/2026 | 0.00 USD |
| 3/16/2026 | 0.00 USD |
| 3/13/2026 | 0.00 USD |
| 3/12/2026 | 0.00 USD |
| 3/11/2026 | 0.00 USD |
| 3/10/2026 | 0.00 USD |
| 3/9/2026 | 0.00 USD |
| 3/6/2026 | 0.00 USD |
| 3/5/2026 | 0.00 USD |
| 3/4/2026 | 0.00 USD |
| 3/3/2026 | 0.00 USD |
| 3/2/2026 | 0.00 USD |
| 2/27/2026 | 0.00 USD |
| 2/26/2026 | 0.00 USD |
| 2/25/2026 | 0.00 USD |
| 2/24/2026 | 0.00 USD |
| 2/23/2026 | 0.00 USD |
| 2/20/2026 | 0.00 USD |
| 2/19/2026 | 0.00 USD |
| 2/18/2026 | 0.00 USD |
| 2/17/2026 | 0.00 USD |
| 2/13/2026 | 0.00 USD |
| 2/12/2026 | 0.00 USD |
| 2/11/2026 | 0.00 USD |
| 2/10/2026 | 0.00 USD |
| 2/9/2026 | 0.00 USD |
| 2/6/2026 | 0.00 USD |
| 2/5/2026 | 0.00 USD |
| 2/4/2026 | 0.00 USD |
| 2/3/2026 | 0.00 USD |
| 2/2/2026 | 0.00 USD |
| 1/30/2026 | 0.00 USD |
| 1/29/2026 | 0.00 USD |
| 1/28/2026 | 0.00 USD |
| 1/27/2026 | 0.00 USD |
| 1/26/2026 | 0.00 USD |
| 1/23/2026 | 0.00 USD |
| 1/22/2026 | 0.00 USD |
| 1/21/2026 | 0.00 USD |
| 1/20/2026 | 0.00 USD |
| 1/16/2026 | 0.00 USD |
| 1/15/2026 | 0.00 USD |
| 1/14/2026 | 0.00 USD |
| 1/13/2026 | 0.00 USD |
| 1/12/2026 | 0.00 USD |
| 1/9/2026 | 0.00 USD |
| 1/8/2026 | 0.00 USD |
| 1/7/2026 | 0.00 USD |
| 1/6/2026 | 0.00 USD |
| 1/5/2026 | 0.00 USD |
| 1/2/2026 | 0.00 USD |
| 12/31/2025 | 0.00 USD |
| 12/30/2025 | 0.00 USD |
| 12/29/2025 | 0.00 USD |
| 12/26/2025 | 0.00 USD |
| 12/24/2025 | 0.00 USD |
| 12/23/2025 | 0.00 USD |
| 12/22/2025 | 0.00 USD |
| 12/19/2025 | 0.00 USD |
| 12/18/2025 | 0.00 USD |
| 12/17/2025 | 0.00 USD |
| 12/16/2025 | 0.00 USD |
| 12/12/2025 | 0.00 USD |
| 12/11/2025 | 0.00 USD |
| 12/10/2025 | 0.00 USD |
| 12/9/2025 | 0.00 USD |
| 12/8/2025 | 0.00 USD |
| 12/5/2025 | 0.00 USD |
| 12/4/2025 | 0.00 USD |
| 12/3/2025 | 0.00 USD |
| 12/2/2025 | 0.00 USD |
| 12/1/2025 | 0.00 USD |
| 11/28/2025 | 0.00 USD |
| 11/26/2025 | 0.00 USD |
| 11/25/2025 | 0.00 USD |
| 11/24/2025 | 0.00 USD |
| 11/21/2025 | 0.00 USD |
| 11/20/2025 | 0.00 USD |
| 11/19/2025 | 0.00 USD |
| 11/18/2025 | 0.00 USD |
| 11/17/2025 | 0.00 USD |
| 11/14/2025 | 0.00 USD |
| 11/13/2025 | 0.00 USD |
| 11/12/2025 | 0.00 USD |
| 11/11/2025 | 0.00 USD |
| 11/10/2025 | 0.00 USD |
| 11/7/2025 | 0.00 USD |
| 11/6/2025 | 0.00 USD |
| 11/5/2025 | 0.00 USD |
| 11/4/2025 | 0.00 USD |
| 11/3/2025 | 0.00 USD |
| 10/31/2025 | 0.00 USD |
| 10/30/2025 | 0.00 USD |
| 10/29/2025 | 0.00 USD |
| 10/28/2025 | 0.00 USD |
| 10/27/2025 | 0.00 USD |
| 10/24/2025 | 0.00 USD |
| 10/23/2025 | 0.00 USD |
| 10/22/2025 | 0.00 USD |
| 10/21/2025 | 0.00 USD |
| 10/20/2025 | 0.00 USD |
| 10/17/2025 | 0.00 USD |
| 10/16/2025 | 0.00 USD |
| 10/15/2025 | 0.00 USD |
| 10/14/2025 | 0.00 USD |
| 10/13/2025 | 0.00 USD |
| 10/10/2025 | 0.00 USD |
| 10/9/2025 | 0.00 USD |
| 10/8/2025 | 0.00 USD |
| 10/7/2025 | 0.00 USD |
| 10/6/2025 | 0.00 USD |
| 10/3/2025 | 0.00 USD |
| 10/2/2025 | 0.00 USD |
| 10/1/2025 | 0.00 USD |
| 9/30/2025 | 0.00 USD |
| 9/29/2025 | 0.00 USD |
| 9/26/2025 | 0.00 USD |
| 9/25/2025 | 0.00 USD |
| 9/24/2025 | 0.00 USD |
| 9/23/2025 | 0.00 USD |
| 9/22/2025 | 0.00 USD |
| 9/19/2025 | 0.00 USD |
| 9/18/2025 | 0.00 USD |
| 9/17/2025 | 0.00 USD |
| 9/16/2025 | 0.00 USD |
| 9/15/2025 | 0.00 USD |
| 9/12/2025 | 0.00 USD |
| 9/11/2025 | 0.00 USD |
| 9/10/2025 | 0.00 USD |
| 9/9/2025 | 0.00 USD |
| 9/8/2025 | 0.00 USD |
| 9/5/2025 | 0.00 USD |
| 9/4/2025 | 0.00 USD |
| 9/3/2025 | 0.00 USD |
| 9/2/2025 | 0.00 USD |
| 8/29/2025 | 0.00 USD |
| 8/28/2025 | 0.00 USD |
| 8/27/2025 | 0.00 USD |
| 8/26/2025 | 0.00 USD |
| 8/25/2025 | 0.00 USD |
| 8/22/2025 | 0.00 USD |
| 8/21/2025 | 0.00 USD |
| 8/20/2025 | 0.00 USD |
| 8/19/2025 | 0.00 USD |
| 8/18/2025 | 0.00 USD |
| 8/15/2025 | 0.00 USD |
| 8/14/2025 | 0.00 USD |
| 8/13/2025 | 0.00 USD |
| 8/12/2025 | 0.00 USD |
| 8/11/2025 | 0.00 USD |
| 8/8/2025 | 0.00 USD |
| 8/7/2025 | 0.00 USD |
| 8/6/2025 | 0.00 USD |
| 8/5/2025 | 0.00 USD |
| 8/4/2025 | 0.00 USD |
| 8/1/2025 | 0.00 USD |
| 7/31/2025 | 0.00 USD |
| 7/30/2025 | 0.00 USD |
| 7/29/2025 | 0.00 USD |
| 7/28/2025 | 0.00 USD |
Psycheceutical Bioscience Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Psycheceutical Bioscience Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEk USD |
|---|
| EBITM USD |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 1,000.00 | 1,000.00 | 1,000.00 | – | – | – | – | – | – | – | – | – |
| – | – | – | -1.00 | – | – | – | – | -1.00 | – | – | – | – | – | -1.00 | -11.00 |
| – | – | – | – | – | – | – | – | -1.00 | – | – | -1.00 | – | – | -1.00 | -16.00 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,500.00 |
| 0.25 | 0.28 | 1.00 | 1.09 | 1.29 | 1.29 | 1.29 | 258.93 | 258.93 | 138.87 | 50.64 | 50.94 | 258.93 | 68.80 | 70.84 | 258.93 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Psycheceutical Bioscience generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Psycheceutical Bioscience retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Psycheceutical Bioscience's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Psycheceutical Bioscience has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Psycheceutical Bioscience's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Psycheceutical Bioscience stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Psycheceutical Bioscience Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Psycheceutical Bioscience business model & stock analysis
Psycheceutical Bioscience SWOT Analysis
Strengths
Blue Water Ventures International Inc has several strengths that contribute to its success:
- Strong and experienced management team with expertise in underwater archaeological recovery
- Established partnerships with universities and research institutions
- Innovative technology and equipment for deep-sea exploration
- Proven track record of successful underwater recovery operations
Weaknesses
Blue Water Ventures International Inc faces the following weaknesses that could hinder its growth:
- High operational costs associated with deep-sea exploration and recovery
- Dependence on external funding sources for large-scale projects
- Relatively small team, limiting capacity for simultaneous projects
- Price volatility of precious metals and artifacts, affecting profitability
Opportunities
Blue Water Ventures International Inc could leverage the following opportunities in the market:
- Increasing demand for underwater treasure recovery and historical artifact discovery
- Growing interest in deep-sea exploration for scientific research purposes
- Potential partnerships with government agencies for marine conservation initiatives
- Expansion into new geographical regions with untapped underwater treasure potential
Threats
Blue Water Ventures International Inc faces the following threats that could impact its operations:
- Stringent regulations governing underwater recovery and sales of historical artifacts
- Competition from other underwater exploration companies and salvage operators
- Risk of unforeseen environmental and natural disasters during recovery operations
- Market volatility and economic downturns impacting demand for luxury artifacts
Psycheceutical Bioscience Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Psycheceutical Bioscience historical P/E ratio, EBIT multiple, and P/S ratio
Psycheceutical Bioscience annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Psycheceutical Bioscience shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Psycheceutical Bioscience Executives and Management Board
Dr. Neilank Jha
Executive Chairman of the Board, Chief Executive Officer · since 2023
Alan Parks
Chief Financial Officer
Mr. Chad Harman
Chief Operating Officer
Mr. John Arnone
(64)Director - Business Development
Elizabeth Weeks-Webb
Executive Assistant and Logistics Director
Frequently asked questions about Psycheceutical Bioscience
The business model of Blue Water Ventures International Inc. involves exploring, recovering, and preserving historically significant shipwrecks and artifacts. Blue Water Ventures operates as an archaeological research, recovery, and exploration company, seeking out underwater treasure troves and conducting thorough investigations to protect cultural heritage. By collaborating with archaeologists, historians, and scholars, Blue Water Ventures aims to contribute to the world's understanding of maritime history. Through its meticulous recovery techniques and ethical practices, the company aims to generate value from these artifacts while respecting their historical importance.
Psycheceutical Bioscience stock
Psycheceutical Bioscience Peer Group
Psycheceutical Bioscience FIGI
All fundamentals and in-depth analysis of Psycheceutical Bioscience
Our stock analysis for Psycheceutical Bioscience stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Psycheceutical Bioscience. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.